This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...